Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Express Scripts
Baxter
Harvard Business School
McKinsey

Last Updated: May 24, 2022

THYQUIDITY Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

When do Thyquidity patents expire, and what generic alternatives are available?

Thyquidity is a drug marketed by Vistapharm and is included in one NDA. There is one patent protecting this drug.

This drug has eleven patent family members in eleven countries.

The generic ingredient in THYQUIDITY is levothyroxine sodium. There are ten drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Summary for THYQUIDITY
International Patents:11
US Patents:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Formulation / Manufacturing:see details
Drug Prices: Drug price information for THYQUIDITY
What excipients (inactive ingredients) are in THYQUIDITY?THYQUIDITY excipients list
DailyMed Link:THYQUIDITY at DailyMed
Drug patent expirations by year for THYQUIDITY
Drug Prices for THYQUIDITY

See drug prices for THYQUIDITY

US Patents and Regulatory Information for THYQUIDITY

THYQUIDITY is protected by one US patents.

Patents protecting THYQUIDITY

Method for the preparation of a levothyroxine solution
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vistapharm THYQUIDITY levothyroxine sodium SOLUTION;ORAL 214047-001 Nov 30, 2020 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for THYQUIDITY

See the table below for patents covering THYQUIDITY around the world.

Country Patent Number Title Estimated Expiration
Poland 2683361 See Plans and Pricing
Croatia P20151421 See Plans and Pricing
Slovenia 2683361 See Plans and Pricing
Hungary E028423 See Plans and Pricing
Serbia 54524 POSTUPAK PRIPREME RASTVORA LEVOTIROKSINA (METHOD FOR THE PREPARATON OF A LEVOTHYROXINE SOLUTION) See Plans and Pricing
Denmark 2683361 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Mallinckrodt
Johnson and Johnson
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.